Additionally, the DiLumen C2 also employs two 6mm working channels at the 3 and 9 o’clock position of the endoscope which accommodates the DiLumen Ig grasper and the DiLumen ls scissor. The mechanics of the DiLumen C2 addresses the limitations of the Endoscopic Submucosal Dissection (ESD), like grasping and removing tissue from the intestines.

Apart from the two unique technologies, Lumendi unveiled another state-of-the-art technology, the DiLumen +DR Dynamic Retraction System. The DiLumen +DR is a new element of the fore balloon assembly that facilitates tissue manipulation for resection of polyps and easier dissection, thereby eliminating the need for surgical intervention. The new technology provides best-in-class tissue retraction, continuous tissue tension, and superior visualization of submucosal tissue planes that helps in precise dissection. In addition to this, the DiLumen +DR System can also be attached to a large pedunculated polyp via a detachable noose.

Peter Johann, the CEO of Lumendi says, “The modification has the potential to revolutionize tissue manipulation during both ESD and EMR. Current methods of retraction for ESD involve anchoring a spring to a clip or using floss and a clip to create counter traction along the oral side of the polyp.”

One of the popular cases where DiLumen technology resulted in a profitable solution was that of Patrick Hellen, a patient. In one of Hellen’s routine diagnosis, a large polyp was found in his cecum - a pouch-like organ connected to the junction of the small and large intestines. Things got severe for Hellen when doctors failed to remove the polyp even after two surgeries. With the DiLumen device, doctors got a better sight into the colon remove the large polyp. A follow-up diagnosis showed no re-growth of the polyp, indicating a successful treatment.

Since its foundation in 2014, Lumendi has been improving healthcare by developing and subsequently applying medical technologies that reduce the level of patient intervention and procedure time, thereby decreasing costs and positively impacting the recovery rates. Lumendi’s products enable clinicians to perform existing procedures more proficiently and usher a new era to treat conditions as compared to the traditional methods that required abdominal surgery. In just five years of service, Lumendi has acquired a significant position in the med-tech market by partnering with top organizations like the Weill Cornell Medical College and New York- Presbyterian Hospital to understand the various challenges and develop innovative solutions to improve lives in cost-effective ways and positively impact recovery rates and outcomes.